Skip to main content
Log in

Adalimumab/infliximab

Psoriasiform lesions: 8 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Buisson A, Cuny JF, Barbaud A, Schmutz JL, Bigard MA, Gueant JL, Peyrin-Biroulet L.Methotrexate for psoriasiform lesions associated with anti-tumour necrosis factor therapy in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics 35: 1175-80, No. 10, May 2012. Available from: URL: http://dx.doi.org/10.1111/j.1365-2036.2012.05082.x - France

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adalimumab/infliximab. React. Wkly. 1416, 7 (2012). https://doi.org/10.2165/00128415-201214160-00020

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214160-00020

Keywords

Navigation